Global Regulatory Strategy: 23 Questions With Claire Marasco

As developers seek to bring their cell and gene therapies to market, navigating the industry’s shifting regulatory landscape and planning for approval across multiple regions can pose challenges. Regulatory guidance continues to evolve and keep pace with innovation in the space, and leveraging a partner with regulatory expertise can help you avoid delays and accelerate your product’s approval timeline.

Forge Biologics has experience with US, EU, and Canadian regulatory bodies, and is building out experience with the UK, Japan, Korea, and more regions. Learn how Forge is poised to ensure your product can reach patients in need around the globe.